Nifty Pharma outperforms benchmark, up 2%; Cipla, Sun Pharma hit 52-wk high ...Middle East

Shares of Glenmark Pharma, Granules India, Divi's Laboratories, Torrent Pharma, Lupin and Aurobindo Pharma, surged in the range of 2 per cent to 6 per cent in Monday's intra-day trade

Hence then, the article about nifty pharma outperforms benchmark up 2 cipla sun pharma hit 52 wk high was published today ( Monday 03/10/2022 - 10:16 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Nifty Pharma outperforms benchmark, up 2%; Cipla, Sun Pharma hit 52-wk high )

Also on site :

• NIDS Co., Ltd. Expands 'Airvom' Supply to High-Traffic Facilities, Strengthening Its Air Quality Management Solutions Business
• Advantech Powers High-Density Edge Infrastructure with the Intel Atom P6900 Processor-Based SOM-5994 Module
• South Sudan Courts Oil Investors as Sudan’s Warring Forces Take Their Share